OPTION AGREEMENTOption Agreement • July 11th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 11th, 2016 Company Industry JurisdictionThis Option Agreement (the “Agreement”) dated as of March 17, 2015 (the “Effective Date”), is entered into by and between Fortress Biotech, Inc. (“Fortress”), a Delaware Corporation having a place of business at 3 Columbus Circle, 15th Floor, New York, NY 10019, and TG Therapeutics, Inc. (“TG”), a Delaware Corporation having a place of business at 3 Columbus Circle, 15th Floor, New York, NY 10019, with respect to the following:
OPTION AGREEMENTOption Agreement • May 16th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 16th, 2016 Company Industry JurisdictionThis Option Agreement (the “Agreement”) dated as of March 17, 2015 (the “Effective Date”), is entered into by and between Fortress Biotech, Inc. (“Fortress”), a Delaware Corporation having a place of business at 3 Columbus Circle, 15th Floor, New York, NY 10019, and TG Therapeutics, Inc. (“TG”), a Delaware Corporation having a place of business at 3 Columbus Circle, 15th Floor, New York, NY 10019, with respect to the following: